Discovery of marinopyrrole A (maritoclax) as a selective ...
https://www.ncbi.nlm.nih.gov/pubmed/22311987
Importantly, maritoclax selectively kills Mcl-1-dependent, but not Bcl-2- or Bcl-X(L)-dependent, leukemia cells and markedly enhances the efficacy of ABT-737 against hematologic malignancies, including K562, Raji, and multidrug-resistant HL60/VCR, by ∼60- to 2000-fold at 1-2 μM.
DA: 48 PA: 100 MOZ Rank: 41